If You Invested $1,000 in Inovio Pharmaceuticals in January, This Is How Much You'd Have Now
Investors who owned Inovio Pharmaceuticals (NASDAQ: INO) and held the stock through the year have been well rewarded for taking a position in the high-risk, high-reward biotech.
A $1,000 investment in Inovio at the beginning of January is currently worth $5,133, over a 400% increase in less than 10 months.
As the pandemic started, Inovio moved fairly quickly to design a vaccine, INO-4800, that could potentially protect people against the novel coronavirus. The company received some outside funding from the Coalition for Epidemic Preparedness Innovations, the Bill & Melinda Gates Foundation, and the Department of Defense.
Source Fool.com
